ams and Precision Biomonitoring announce global partnership to enable pandemic control through the development of a rapid saliva antigen testing device for Covid-19 (SARS-CoV-2) The easy-to-use, lab-free Covid-19 (SARS-CoV-2) antigen test solution aims to provide reliable results in around 15 minutes at the point-of-care The objective is affordable, rapid mass testing by analyzing saliva samples […]
continue reading